XpresSpa Group Inc. (XSPA)
NASDAQ: XSPA
· Real-Time Price · USD
0.66
-0.03 (-4.93%)
At close: Oct 25, 2022, 6:00 AM
XpresSpa Revenue Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Products Revenue | 603K | 1.42M | 936K | 880K | 2.17M | 747K | 596K | 622K | 542K | 421K | 345K | 361K |
| Products Revenue Growth | -57.57% | +51.82% | +6.36% | -59.45% | +190.50% | +25.34% | -4.18% | +14.76% | +28.74% | +22.03% | -4.43% | n/a |
| Services Revenue | 6.42M | 14.77M | 7.49M | 8.4M | 21.28M | 6.71M | 5.77M | 5.39M | 4.92M | 4.79M | 3.78M | 3.66M |
| Services Revenue Growth | -56.54% | +97.33% | -10.90% | -60.52% | +217.20% | +16.23% | +6.99% | +9.57% | +2.86% | +26.74% | +3.22% | n/a |
Revenue by Geography
| Period Ending | Mar 31, 2025 |
|---|---|
| Non-Us Revenue | 1.32M |
| Non-Us Revenue Growth | n/a |
| United States Revenue | 5.71M |
| United States Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.28M | 4.31M | 1.47M | 4.53M | 3.07M | 4.02M | 3.91M | 6.09M | 6.98M | 6.45M | 7.56M | 10.19M | 9.85M | 5.2K | 4.65M | 4.51M | 4.97M | 5.79M | 4.56M | 4.5M | 6.55M | 4.57M | 4.08M | 5.25M | 7.92M | 5.82M | 5.75M | 6.25M | 692K | 7.37M | 8.3M | 8.76M | 4.53M | 3.84M | 15.65M | 3.8M | 3.85M | 2.91M | 3.11M | 3.8M |
| Selling, General, and Administrative Revenue Growth | -0.72% | +193.07% | -67.49% | +47.30% | -23.51% | +2.82% | -35.87% | -12.69% | +8.21% | -14.70% | -25.81% | +3.44% | +189449.65% | -99.89% | +3.06% | -9.26% | -14.23% | +27.10% | +1.31% | -31.30% | +43.20% | +12.20% | -22.37% | -33.72% | +36.04% | +1.31% | -8.03% | +803.03% | -90.61% | -11.22% | -5.26% | +93.31% | +17.93% | -75.46% | +311.65% | -1.25% | +32.16% | -6.33% | -18.17% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47K | 113K | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | -58.41% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |